|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 209/12 | (2006.01) |
| A61P 9/12 | (2006.01) | ||
| A61P 9/10 | (2006.01) | ||
| A61P 9/04 | (2006.01) | ||
| A61P 27/06 | (2006.01) | ||
| A61P 31/12 | (2006.01) |
| (11) | Patento numeris | 1717226 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 06117363.9 |
| Europos patento paraiškos padavimo data | 2005-03-17 | |
| (97) | Europos patento paraiškos paskelbimo data | 2006-11-02 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2009-01-21 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 20040046904 | 2004-03-19 | CH |
| (72) |
Herold, Peter, CH
Stutz, Stefan, CH
Mah, Robert, CH
Tschinke, Vincenzo, CH
Stojanovic, Aleksandar, CH
Jotterand, Nathalie, CH
Quirmbach, Michael, CH
Behnke, Dirk, DE
Marti, Christiane, CH
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | 2,7-SUBSTITUTED 5-AMINO-4-HYDROXY-8-(1H-INDOL-5-YL)-OCTAN AMIDE DERIVATIVES AS RENIN INHIBITORS FOR THE TREATMENT OF HYPERTENSION |
| 2,7-SUBSTITUTED 5-AMINO-4-HYDROXY-8-(1H-INDOL-5-YL)-OCTAN AMIDE DERIVATIVES AS RENIN INHIBITORS FOR THE TREATMENT OF HYPERTENSION |